Textile · Founded 1985 · www.fiberwebindia.com · BSE 507910 · NSE FIBERWB IN · ISIN INE296C01020
No Notes Added Yet
1. Business Overview
Fiberweb (India) Ltd. is engaged in the manufacturing and selling of a wide range of non-woven fabrics, primarily using Spunbond and Meltblown technologies. These technical textiles are critical components in various products across hygiene, medical, industrial, agricultural, and automotive sectors. The company's core business model revolves around producing specialized non-woven materials (such as PP Spunbond, Meltblown, SMMS) which are then supplied as intermediate goods to other manufacturers who incorporate them into finished products like diapers, sanitary napkins, surgical gowns, masks, filtration media, geotextiles, and crop covers. Revenue is generated through the sale of these non-woven fabrics.
2. Key Segments / Revenue Mix
Fiberweb (India) Ltd. primarily operates in the technical textiles segment, specifically focusing on non-woven fabrics. While the company does not typically report a granular revenue mix by end-use segment with specific percentages, its products cater to:
Hygiene: Diapers, sanitary napkins, adult incontinence products.
Medical & Healthcare: Surgical gowns, drapes, masks, sterilization wraps.
Industrial: Filtration media, protective apparel, automotive interiors.
Agricultural: Crop covers, weed control fabrics.
Packaging & Others: Various specialty applications.
The primary technology used and thus its product segments are PP Spunbond, Meltblown, and composite fabrics like SMMS.
3. Industry & Positioning
Fiberweb operates within the Indian technical textiles industry, a high-growth but relatively nascent segment of the broader textile sector. The industry is characterized by increasing domestic demand driven by rising hygiene awareness, healthcare expenditure, and industrialization. Fiberweb is one of the established players in the non-woven fabrics segment in India, particularly in Spunbond and Meltblown technologies. It competes with other domestic non-woven manufacturers and, to some extent, with imports. Its positioning is that of a specialized manufacturer capable of producing a variety of grades for diverse applications, aiming to capture market share in a segment historically reliant on imports.
4. Competitive Advantage (Moat)
Fiberweb's competitive advantages primarily stem from:
Process Expertise & Technology: Specialization in advanced non-woven technologies like Spunbond and Meltblown, which require significant capital investment and technical know-how.
Product Diversification: Ability to produce a wide range of non-woven fabrics for multiple applications, reducing dependence on a single end-market.
Customer Relationships: Established relationships with key manufacturers in hygiene, medical, and industrial sectors, acting as a reliable supplier for critical components.
Scale of Operations (within its niche): As one of the larger Indian manufacturers in specific non-woven technologies, it benefits from some economies of scale in procurement and production compared to smaller players.
5. Growth Drivers
Rising Hygiene Awareness: Increasing demand for disposable hygiene products (diapers, sanitary napkins) in India, driven by population growth, urbanization, and improving living standards.
Growth in Healthcare Sector: Expanding healthcare infrastructure and increasing focus on infection control measures boosting demand for medical textiles (masks, gowns, drapes).
Government Initiatives: "Make in India" focus and initiatives to promote technical textiles in India could provide an impetus to domestic manufacturers.
Industrial & Agricultural Applications: Growing demand from various industrial sectors (filtration, automotive) and agricultural sector (crop protection, weed control) for specialized non-woven fabrics.
Import Substitution: As domestic capabilities grow, there is potential to substitute previously imported technical textiles.
6. Risks
Raw Material Price Volatility: Key raw materials like polypropylene (PP) are crude oil derivatives, making the company susceptible to fluctuations in crude oil prices, impacting profitability.
Intense Competition: Growing competition from both domestic and international players (imports) could pressure pricing and margins.
Technological Obsolescence: Rapid advancements in non-woven technology require continuous investment in R&D and machinery to remain competitive.
Customer Concentration: Potential reliance on a few large customers in specific segments could pose a risk if those relationships deteriorate.
Economic Slowdown: A general economic downturn could impact demand across industrial, automotive, and even discretionary hygiene product segments.
7. Management & Ownership
Fiberweb (India) Ltd. is promoted by the Vora family. Mr. Narendra Vora is the Chairman & Managing Director. The management team has significant experience in the technical textiles and non-wovens industry. Promoter holding typically remains substantial, indicating their continued commitment to the business. The company is publicly listed, with ownership distributed among promoters, institutional investors, and public shareholders.
8. Outlook
Fiberweb (India) Ltd. operates in a structurally growing segment of the Indian textile industry, driven by increasing per capita consumption of hygiene and healthcare products, industrialization, and evolving agricultural practices. The company's established manufacturing capabilities in advanced non-woven technologies position it to capitalize on these trends. However, profitability remains susceptible to volatile raw material prices and competitive pressures, which necessitate efficient operations and continuous product innovation. The ability to manage input costs, expand product offerings, and maintain strong customer relationships will be crucial for sustained growth amidst an evolving industry landscape.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 15 | 21 | 24 | 25 | 25 | 27 | 29 | 20 | 26 | 10 |
| Other Income | 0 | 0 | 1 | 1 | 0 | -0 | 0 | 0 | 0 | 1 |
| Total Income | 15 | 21 | 26 | 26 | 25 | 27 | 29 | 21 | 26 | 10 |
| Total Expenditure | 13 | 16 | 21 | 20 | 20 | 20 | 23 | 17 | 20 | 8 |
| Operating Profit | 2 | 5 | 5 | 5 | 6 | 6 | 7 | 4 | 6 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 3 | 4 | 4 | 4 | 5 | 5 | 2 | 4 | 2 |
| Provision for Tax | -0 | -0 | 1 | 1 | 1 | 1 | 0 | -0 | 0 | 3 |
| Profit After Tax | 2 | 4 | 3 | 4 | 4 | 4 | 5 | 3 | 4 | -2 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 2 | 4 | 3 | 4 | 4 | 4 | 5 | 3 | 4 | -2 |
| Adjusted Earnings Per Share | 0.5 | 1.2 | 1 | 1.2 | 1.2 | 1.3 | 1.8 | 0.9 | 1.4 | -0.5 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 69 | 62 | 104 | 206 | 153 | 98 | 107 | 95 | 66 | 86 | 101 | 85 |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Total Income | 69 | 62 | 104 | 206 | 153 | 99 | 109 | 96 | 67 | 87 | 103 | 86 |
| Total Expenditure | 67 | 54 | 87 | 176 | 127 | 81 | 85 | 80 | 64 | 74 | 80 | 68 |
| Operating Profit | 2 | 8 | 17 | 30 | 26 | 18 | 24 | 16 | 3 | 12 | 23 | 20 |
| Interest | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 0 | 3 | 3 | 3 | 5 | 5 | 5 | 2 | 2 | 4 | 5 | 4 |
| Exceptional Income / Expenses | 0 | 3 | 0 | 0 | -16 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 7 | 14 | 27 | 6 | 12 | 18 | 14 | -1 | 7 | 17 | 13 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 2 | -0 | 0 | 2 | 3 |
| Profit After Tax | 2 | 7 | 14 | 27 | 6 | 10 | 14 | 11 | -0 | 7 | 15 | 10 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 2 | 7 | 14 | 27 | 6 | 10 | 14 | 11 | -0 | 7 | 15 | 10 |
| Adjusted Earnings Per Share | 0.9 | 2.8 | 5.4 | 9.3 | 2 | 3.6 | 5 | 3.9 | -0.1 | 2.5 | 5.2 | 3.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 17% | 2% | 1% | 4% |
| Operating Profit CAGR | 92% | 13% | 5% | 28% |
| PAT CAGR | 114% | 11% | 8% | 22% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -32% | -3% | -5% | 3% |
| ROE Average | 9% | 4% | 6% | 26% |
| ROCE Average | 10% | 5% | 8% | 11% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | -53 | -45 | 89 | 130 | 135 | 145 | 158 | 154 | 154 | 161 | 176 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 122 | 103 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 7 | 8 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | -0 | -1 | -1 | -2 | -2 | -2 |
| Total Current Liabilities | 4 | 3 | 2 | 23 | 9 | 14 | 7 | 6 | 8 | 3 | 7 |
| Total Liabilities | 73 | 62 | 92 | 153 | 144 | 159 | 165 | 160 | 167 | 170 | 191 |
| Fixed Assets | 54 | 41 | 39 | 84 | 81 | 78 | 96 | 84 | 109 | 117 | 128 |
| Other Non-Current Assets | 2 | 2 | 7 | 5 | 15 | 16 | 8 | 11 | 11 | 1 | 2 |
| Total Current Assets | 16 | 19 | 46 | 64 | 48 | 65 | 62 | 64 | 48 | 52 | 61 |
| Total Assets | 73 | 62 | 92 | 153 | 144 | 159 | 165 | 160 | 167 | 170 | 191 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 4 | 6 | 22 | 5 | 4 | 8 | 7 | 6 | 5 | 4 |
| Cash Flow from Operating Activities | 1 | 6 | 5 | 16 | 11 | 4 | 22 | 9 | 18 | 1 | 12 |
| Cash Flow from Investing Activities | 1 | 13 | -6 | -47 | -12 | -4 | -16 | -10 | -26 | -2 | -17 |
| Cash Flow from Financing Activities | -0 | -17 | 16 | 14 | -0 | 5 | -7 | 1 | 7 | 0 | 2 |
| Net Cash Inflow / Outflow | 2 | 2 | 15 | -17 | -1 | 5 | -2 | -0 | -2 | -1 | -2 |
| Closing Cash & Cash Equivalent | 4 | 6 | 22 | 5 | 4 | 8 | 7 | 6 | 5 | 4 | 2 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.92 | 2.82 | 5.36 | 9.25 | 2.01 | 3.58 | 4.99 | 3.94 | -0.1 | 2.52 | 5.21 |
| CEPS(Rs) | 0.98 | 4.1 | 6.37 | 10.38 | 3.58 | 5.21 | 6.77 | 4.7 | 0.72 | 3.91 | 6.88 |
| DPS(Rs) | 0 | 0 | 0 | 0.5 | 0.2 | 0.5 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | -33.22 | -23.84 | 27.73 | 39.85 | 41.65 | 45.19 | 49.68 | 53.62 | 53.51 | 56.04 | 61.25 |
| Core EBITDA Margin(%) | 3.02 | 11.89 | 16.14 | 14.59 | 16.71 | 17.29 | 20.91 | 15.79 | 3.27 | 13.48 | 20.57 |
| EBIT Margin(%) | 3.16 | 11.15 | 13.65 | 13.03 | 3.87 | 13.78 | 17.24 | 14.58 | 0.21 | 9.88 | 17.5 |
| Pre Tax Margin(%) | 2.72 | 10.88 | 13.47 | 12.93 | 3.79 | 12.17 | 17.18 | 14.47 | -0.8 | 8.56 | 16.72 |
| PAT Margin (%) | 2.72 | 10.88 | 13.47 | 12.93 | 3.79 | 10.49 | 13.37 | 11.88 | -0.45 | 8.45 | 14.81 |
| Cash Profit Margin (%) | 2.87 | 15.81 | 16.02 | 14.51 | 6.76 | 15.29 | 18.15 | 14.18 | 3.12 | 13.09 | 19.56 |
| ROA(%) | 2.82 | 10.58 | 18.57 | 21.76 | 3.89 | 6.8 | 8.88 | 6.99 | -0.18 | 4.31 | 8.33 |
| ROE(%) | 0 | 0 | 208.2 | 28.27 | 4.93 | 8.24 | 10.52 | 7.62 | -0.19 | 4.61 | 8.89 |
| ROCE(%) | 4.46 | 15.02 | 24.56 | 28.45 | 5.04 | 10.56 | 13.27 | 9.35 | 0.09 | 5.17 | 10.04 |
| Receivable days | 18.04 | 23.56 | 32.48 | 47.42 | 77.22 | 81.16 | 70.91 | 88.98 | 88.28 | 43.97 | 52.58 |
| Inventory Days | 39 | 44.46 | 31 | 22.88 | 38.05 | 86.25 | 89.35 | 91.07 | 134.62 | 98.25 | 84.04 |
| Payable days | 25.3 | 30.17 | 11.04 | 27.82 | 50.62 | 32.76 | 29.65 | 39.6 | 61.13 | 42.99 | 23.43 |
| PER(x) | 4.77 | 0 | 32.87 | 12.51 | 15.94 | 3.06 | 5.51 | 9.78 | 0 | 12.03 | 7.48 |
| Price/Book(x) | -0.13 | 0 | 6.35 | 2.91 | 0.77 | 0.24 | 0.55 | 0.72 | 0.6 | 0.54 | 0.64 |
| Dividend Yield(%) | 0 | 0 | 0 | 0.43 | 0.63 | 4.56 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.85 | 1.77 | 4.28 | 1.6 | 0.58 | 0.3 | 0.67 | 1.09 | 1.42 | 1.05 | 1.18 |
| EV/Core EBITDA(x) | 51.39 | 13.78 | 26.09 | 10.92 | 3.39 | 1.61 | 3.06 | 6.48 | 27.33 | 7.26 | 5.28 |
| Net Sales Growth(%) | 6.38 | -9.99 | 68.31 | 97.42 | -25.88 | -35.71 | 9.44 | -11.22 | -30.7 | 30.07 | 17.79 |
| EBIT Growth(%) | 687.49 | 208.63 | 98.23 | 86.05 | -77.99 | 128.84 | 36.95 | -24.92 | -98.99 | 5963.7 | 108.67 |
| PAT Growth(%) | 373.2 | 249.42 | 100.56 | 86.97 | -78.3 | 78.22 | 39.52 | -21.13 | -102.64 | 2528.86 | 106.4 |
| EPS Growth(%) | 373.21 | 204.95 | 90 | 72.69 | -78.3 | 78.22 | 39.52 | -21.13 | -102.64 | 2527.79 | 106.4 |
| Debt/Equity(x) | -1.67 | -1.72 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0.04 | 0.04 | 0.05 |
| Current Ratio(x) | 4.2 | 6.28 | 19.97 | 2.77 | 5.57 | 4.64 | 8.51 | 9.99 | 5.7 | 17.17 | 8.18 |
| Quick Ratio(x) | 2.03 | 3.84 | 15.41 | 2.1 | 3.66 | 2.49 | 5.37 | 6.1 | 2.86 | 9.76 | 4.94 |
| Interest Cover(x) | 7.24 | 41.37 | 78.62 | 128.1 | 45.35 | 8.6 | 298.75 | 135.4 | 0.21 | 7.49 | 22.44 |
| Total Debt/Mcap(x) | 12.56 | 0 | 0 | 0 | 0 | 0.19 | 0 | 0 | 0.07 | 0.08 | 0.08 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 46.33 | 46.33 | 46.33 | 46.33 | 46.33 | 46.33 | 46.33 | 46.33 | 46.42 | 34.48 |
| FII | 0.01 | 0.01 | 0.02 | 0 | 0.32 | 0.03 | 0.02 | 0.06 | 0 | 0 |
| DII | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.35 | 0.35 | 0.35 | 0.35 |
| Public | 53.47 | 53.48 | 53.47 | 53.48 | 53.16 | 53.46 | 53.29 | 53.26 | 53.22 | 65.16 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.34 | 0.99 |
| FII | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 1.54 | 1.54 | 1.54 | 1.54 | 1.53 | 1.54 | 1.53 | 1.53 | 1.53 | 1.88 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +17% | +2% | +1% | +4% |
| Operating Profit CAGR | +92% | +13% | +5% | +28% |
| PAT CAGR | +114% | +11% | +8% | +22% |
| Share Price CAGR | -32% | -3% | -5% | +3% |
| ROE Average | +9% | +4% | +6% | +26% |
| ROCE Average | +10% | +5% | +8% | +11% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 46.33 | 46.33 | 46.33 | 46.33 | 46.33 | 46.33 | 46.33 | 46.33 | 46.42 | 34.48 |
| FII | 0.01 | 0.01 | 0.02 | 0 | 0.32 | 0.03 | 0.02 | 0.06 | 0 | 0 |
| DII | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.35 | 0.35 | 0.35 | 0.35 |
| Public | 53.67 | 53.67 | 53.67 | 53.67 | 53.67 | 53.67 | 53.67 | 53.67 | 53.58 | 65.52 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.34 | 0.99 |
| FII | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.54 | 1.89 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.